AlphaStocks

ALV vs AZN

AUTOLIV INC vs ASTRAZENECA PLC — Side-by-Side Stock Comparison

ALV

AUTOLIV INC

5.5

Consider Buy

$107.10

AZN

ASTRAZENECA PLC

8.4

Strong Buy

$200.99

ALV vs AZN: Which is the Better Investment?

AUTOLIV INC (ALV) scores 5.5/10 while ASTRAZENECA PLC (AZN) scores 8.4/10 on AlphaStocks' composite model. ASTRAZENECA PLC has the higher composite rating of Strong Buy. On a P/E basis, AUTOLIV INC trades at 11.2x, making it the more attractively priced of the two.

This comparison is algorithmically generated and is not financial advice.

MetricALVAZN
Scores & Fundamentals
Composite Score5.5/108.4/10
RatingConsider BuyStrong Buy
Price$107.10$200.99
P/E Ratio11.230.4
ROE28.7%21.9%
Market Cap$8B$312B
Fair Value$192.63
Dividend Yield3.0%1.6%
Sector Rank#430 of 1127#3 of 1127
Model Verdicts
PiotroskiStrongStrong
BuffettStrongStrong
GrahamNeutralCaution
LynchNeutralNeutral
GreenblattStrongNeutral
View full ALVanalysis →View full AZNanalysis →
Compare any two stocks →

ALV vs AZN: Which Stock Scores Higher?

AUTOLIV INC (ALV) and ASTRAZENECA PLC (AZN) are among the most compared stocks in the S&P 500. AZN currently leads with a composite score of 8.4/10 (Strong Buy) compared to ALV's 5.5/10 (Consider Buy).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer